Episode 30
electronRX’s Mission for Early Disease Detection with Dr. Bipin Patel
Aired On: November 12, 2024
Hosted By
Dr. Bipin Patel, founder and CEO of UK-based company electronRX, joins host Michael Roberts to talk about his company’s mission for early disease detection in the cardiorespiratory space. You’ll learn more about the electronRX technology, as well as broader issues around early disease detection and how companies in this sector can better empower patients.
Resources
More Episodes
AI’s Role in Proactive Healthcare with Adityo Prakash
April 9, 2024
How Next Gen Technology Will Influence the Future of Healthcare with Dr. Roger Smith
July 23, 2024
In this Episode
- 02:02 Understanding ElectronRx and Its Mission
- 04:45 Innovative Measurement Techniques in Respiratory Health
- 09:53 Challenges with Current Health Monitoring Devices
- 15:04 The Role of Data in Patient Care
- 19:46 The Future of Patient Empowerment and Advocacy
- 24:57 Navigating the Healthcare System and Insurance Dynamics
Quotes From This Episode
What normally happens is that we end up getting diagnosis probably rather later than sooner. But also once we have the diagnosis, there are some interventions put in place and you and I are not going to see the physician for some time, months will go by in between…And not really anybody knows what goes on in between. And therefore the physicians don’t really have the proper picture.
Dr. Bipin Patel
We are capturing physiological signals, combining with other metadata we can capture to really understand how your lung physiology is working, using lots of mathematical algorithms to determine whether you are breathing correctly or incorrectly. And from that, we’re able to diagnose conditions or also at the same time determine whether the condition is actually progressing or, or regressing as a result of, of an intervention.
Dr. Bipin Patel
The mission here is, can we identify stage patients with early conditions so we can go and do something about this? But at the same time, can we find patients who are on treatments where the treatment is not actually being followed correctly or is not working for these people? That’s where we’re heading.
Dr. Bipin Patel
